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bstract
urpose:  Continuous monitoring of liver fibrosis progression in patients is not feasible with the current diagnostic golden standard (needle biopsy).
ecently, magnetic resonance elastography (MRE) has emerged as a promising method for such continuous monitoring. Since there are different
RE methods that could be used in a clinical setting there is a need to investigate whether measurements produced by these MRE methods
re comparable. Hence, the purpose of this pilot study was to evaluate whether the measurements of the viscoelastic properties produced by 2D
stiffness) and 3D (elasticity and ‘Gabs,Elastic’) MRE are comparable.
aterials  and  methods:  Seven patients with diffuse or suspect diffuse liver disease were examined in the same day with the two MRE methods. 2D
RE was performed using an acoustic passive transducer, with a 1.5 T GE 450 W MR system. 3D MRE was performed using an electromagnetic
ctive transducer, with a 1.5 T Philips Achieva MR system. Finally, mean viscoelastic values were extracted from the same anatomical region for
oth methods by an experienced radiologist.
esults:  Stiffness correlated well with the elasticity, R2 = 0.96 (P  < 0.001; slope = 1.08, intercept = 0.61 kPa), as well as with ‘Gabs,Elastic’ R2 = 0.96
P  < 0.001; slope = 0.95, intercept = 0.28 kPa).
onclusion:  This pilot study shows that different MRE methods can produce comparable measurements of the viscoelastic properties of the
iver. The existence of such comparable measurements is important, both from a clinical as well as a research perspective, since it allows for
quipment-independent monitoring of disease progression.
 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
icenses/by-nc-nd/4.0/).
eywords: Liver; Rheology; Elastography; Fibrosis; MRE; MRI
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v
h.  Introduction
The long-term prognosis of chronic liver diseases, caused,
or example, by alcohol, viral hepatitis, non-alcoholic fatty
iver disease (NAFLD), and autoimmune or metabolic disor-
ers, depends principally on the extent and progression of liver
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icenses/by-nc-nd/4.0/).brosis. Histopathological examination of a liver biopsy, con-
entionally considered to be the gold standard for evaluating
epatic fibrosis, has several drawbacks. These include the risk
f complications, inter- and intra-observer variability, inaccurate
taging due to spatial sampling errors and the fact that hetero-
eneous distribution and rate of fibrosis progression, which is
ommonly not constant over time, may not be reflected in a
ingle biopsy [1–7].Animal models as well as data on human liver disease have
emonstrated that fibrosis, and even cirrhosis, may be reversible.
hese observations have stimulated efforts to find non-invasive
cess article under the CC BY-NC-ND license (http://creativecommons.org/
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lternatives allowing a close monitoring of patients and facili-
ating clinical decision-making [8,9].
Serum biomarkers, ultrasound elastography and a number
f magnetic resonance (MR) applications have been proposed
o replace liver biopsy, either as single methods, or in various
ombinations. Among the MR techniques, magnetic resonance
lastography (MRE) appears to be reliable in identifying signif-
cant fibrosis (stage ≥  F2) and AUROC values >0.90 have been
eported [10–12].
MRE is a phase-contrast-based MRI imaging technique. In
rinciple it consists of three key steps: (i) mechanical motion (or
hear waves) is applied to the tissue, either from an external or an
nternal source such as heart motion. (ii) The tissue response to
he stress of this motion is imaged using phase-contrast MRI with
otion encoding gradients. (iii) The image data are processed
o obtain information about viscoelastic properties of the liver
13,14].
In hepatic MRE, various types of external drivers have been
sed to induce the mechanical waves; acoustic, piezoelectric or
neumatic [14]. In this study, two such designs are used, acoustic
nd electromagnetic. For the imaging techniques both 2D and 3D
ethods have been proposed and the presently available com-
ercial system uses the 2D MRE data sampling technique. The
se of either 2D or 3D affects the ability to use more or less com-
lex post-processing algorithms to derive the mechanical proper-
ies of the tissue. The 3D sampling technique, which presently is
ot commercially available, allows for separation of the complex
hear modulus into two basic components, elasticity and viscos-
ty, whereas the commercially available 2D MRE presents the
hear stiffness. Furthermore by using a 2D acquisition technique
here is also an implicit assumption that the shear waves induced
y the driver only propagate in the selected imaging slice, which
s not the case in the 3D technique, where the algorithm solves
he wave propagation in all three dimensions [13].
Since there are different MRE methods that could be used in
 clinical setting there is a need to investigate if the measure-
ents of the viscoelastic properties of the liver produced by these
ifferent MRE methods are comparable. Thus, the purpose of
his pilot study was to compare 2D and 3D MRE, using a com-ercially available 2D MRE system and a 3D MRE research
ystem, with respect to liver stiffness and elasticity in patients
ith diffuse or suspected diffuse liver disease.
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able 1
emographic variables, fibrosis staging and diagnosis.
atient Gender Agea (year) BMI (kg/m2) Biopsy ageb (y
 F 80 22.9 2.4 
 M 33 22.8 3.4 
 M 69 27.8 4.6 
 F 41 20.7 0.9 
 F 75 19.6 3.3 
 F 44 25.6 1.3 
 F 51 27.9 1.9 
a Age refers to the patient’s age when the MRE examinations were performed.
b Biopsy age refers to the time in-between the initial biopsy and when the MRE ex
c Biopsy localization refers to either the left or the right liver lobe.
d Fibrosis stage according to Batts–Ludwig fibrosis scoring; 1 = portal fibrosis, 2 = 
e Diagnosis; PSC = primary sclerosing cholangitis, NAFLD = non-alcoholic fatty lif Radiology Open 2 (2015) 66–70 67
.  Materials  and  methods
.1.  Patients
In this study, seven patients were examined in the course of
ne day (2012). The patients were separately recruited from an
n-going study [15]. These patients were selected due to their
levated serum alanine aminotransferase (ALT) and/or alkaline
hosphatase (ALP) levels. Physical examination and laboratory
ests revealed no signs of liver cirrhosis. The biopsy and the
istopathological grading of these patients were gained from the
ecords of the previously mentioned on-going study [15]. Table 1
resents basic descriptive parameters as well as the time between
he initial biopsy and the MRE examinations (”Biopsy age” in
able 1). The time between each MRE acquisition (2D and 3D
RE) was dependent on how long it took for the patient to move
etween the two MR systems within the hospital (typically less
han 10 min).
All participants gave their informed consent before the start
f the study. The study was approved by the regional ethics
ommittee (Reference No. M72-07, T92-08).
.2.  Data  acquisition  and  image  analysis
.2.1.  2D  MRE
The 2D MRE (MR-Touch, GE Medical Systems, Milwaukee,
S) was performed by transmitting mechanical waves at 60 Hz
nto the right side of the liver by a passive transducer (acoustic)
laced on the anterior chest wall to the right of the xiphoid
rocess of the patient, who was lying in a supine position. A
.5 T GE 450 W MR system (GE Healthcare, Milwaukee, US)
as used, along with a phased array body coil (HD8 Torso, using
ll 8 coil elements). The quantitative shear stiffness maps were
enerated by processing the acquired images with a previously
escribed local frequency estimation inversion algorithm [16].
.2.2. 3D  MRE
The principle of the 3D MRE method used has been describedreviously [17,18]. In short, mechanical waves of 56 Hz were
ransmitted into the right side of the liver by an active trans-
ucer (electromagnetic) that was placed on the anterior chest
all to the right of the xiphoid process of the patient, who
ear) Biopsy localizationc Fibrosis staged Diagnosise
Right 2 PSC
Left 3 PSC
Left 4 NAFLD
Left 3 AIH
Right 2 AIH, PBC
Right 2 AIH
Left 1 AIH
aminations were performed.
periportal fibrosis, 3 = septal fibrosis, 4 = cirrhosis.
ver disease, AIH = autoimmune hepatitis, PBC = primary biliary cirrhosis.
68 M.F. Forsgren et al. / European Journal o
Table 2
Summary of the MR protocols.
2D MRE, GRE 3D MRE, GRE
MR system GE 450 W, 1.5 T Philips Achieva, 1.5 T
Field of view 440 mm × 440 mm 320 mm × 256 mm
Matrix 256 × 64 80 × 38
Slice thickness 10 mm 4 mm
# Slices 4 9
Flip angle 30◦ 15◦
TR 50 ms 112 ms
TE 21.7 ms 9.21 ms
Acceleration ASSET = 2 SENSE = 2
# Breath-hold 4 4
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important step forward towards the creation of a comprehensive
non-invasive MR-toolset for measuring and monitoring various
histopathological parameters.
Table 3
Measured viscoelastic properties.
Patient Fibrosis
stagea
3D MREb 2D MREb
Elasticity (kPa) Gabs,Elastic (kPa) Stiffness (kPa)
1 2 1.96 ± 0.37 2.34 ± 0.41 3.03 ± 0.55
2 3 0.77 ± 0.67 1.76 ± 0.36 1.63 ± 0.25
3 4 5.72 ± 2.58 7.03 ± 2.45 7.06 ± 1.62as lying in a supine position. A 1.5 T Philips Achieva MR
ystem (Philips HealthCare, Best, The Netherlands) was used,
long with a phased array body coil (Sense TorsoXL, using all
6 coil elements). The shear waves were obtained by apply-
ng the curl operator and using the Voigt rheological model to
btain shear elasticity maps. Details of the elasticity/viscosity
ap calculations can be found elsewhere [17,18].
Relevant protocol parameters are summarized in Table 2.
.2.3. Image  analysis  of  the  viscoelastic  maps
For each patient, a region of interest (ROI) was placed man-
ally by a radiologist (with more than 20 years’ experience in
bdominal radiology; BN) in an appropriate single 10 mm slice
cquired using 2D MRE. The shape and size of the ROI were
imited by the uncertainty mesh calculated by the 2D MRE sys-
em. Thereafter a corresponding ROI for the 3D MRE was placed
anually over three slices such that it covered the same anatom-
cal region as with the 2D MRE measurement (each 3D MRE
lice had a thickness of 4 mm). This yielded a total cranio-caudal
overage of the ROIs equal to 10 mm (for the 2D MRE) and
2 mm (for the 3D MRE). Subsequently, the mean and standard
eviations (unit kPa) of the stiffness (2D MRE), elasticity (3D
RE) and ‘Gabs,Elastic’ (3D MRE) both in units of kPa were
alculated for each ROI and patient. ‘Gabs,Elastic’ is the absolute
alue of the shear modulus, which in principle is equivalent to
he viscoelastic property shear stiffness.
.3.  Statistics  and  computer  software
Statistical analyses included a linear regression with a 95%
onfidence interval on the fitted regression parameters; R2 was
sed as a measure of model fit and data correlation. The sta-
istical analyses were performed using Mathematica (9.0.1.0,
olfram Research Inc., Champaign, IL, U.S.), the ROI drawing
nd elastogram quantification for the data from the 2D MRE
as performed on a PACS-system (PACS IDS7, 15.1.10.8, Sec-
ra AB, Linköping, Sweden), and for the 3D MRE the ROIs
ere placed and analysed using a custom software package
mplemented in ROOT (5.30/01, CERN, Geneva, Switzerland)
enerously provided by R. Sinkus (Kings College, London, UK).
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.  Results
The measured values for all patients are presented in Table 3.
n example of a ROI placement in the viscoelastic maps is
hown in Fig. 1. Both the elasticity and the ‘Gabs,Elastic’ corre-
ated well with the stiffness measurement carried out on the 2D
RE system (Fig. 2a and b), as was shown by the elasticity
nd stiffness correlation R2 = 0.96 (P  < 0.001), slope = 1.08
P < 0.001, 95% CI = {0.83;1.33}), intercept = 0.61 kPa
P = 0.08, 95% CI = {−0.12;1.34}), ‘Gabs,Elastic’ and stiffness
orrelation R2 = 0.96 (P  < 0.001), slope = 0.95 (P  < 0.001,
5% CI = {0.72;1.18}), intercept = 0.28 kPa (P  = 0.43, 95%
I = {−0.56;1.12}).
.  Discussion
The main result was that there was a very good correla-
ion between the elastograms obtained from the two different
RE methods, one using a passive acoustic transducer and
D acquisition and one using an active electromagnetic trans-
ucer and 3D acquisition; in both comparisons (i.e., elasticity
nd ‘Gabs,Elastic’ vs. stiffness) the linear factor in the regres-
ion was close to one. If these observations hold true in larger
tudies, the existence of robust and reliable absolute quantifi-
ation tools from different manufacturers producing directly
omparable data is encouraging, both from a patient as well
s a research perspective. However, care should be taken when
omparing the elasticity and stiffness measures, since they have
lightly different physical interpretations, and a standardized
ay of representing/processing MRE would be very benefi-
ial. In recent publications the authors have argued that the
se of multi-frequency MRE (MMRE) could allow for such
 robust standardization of MRE [19,20] – this would be a
romising enhancement for the diagnosis and monitoring of
isease progression in a clinical setting. An added value of the
MRE approach is that it potentially also allows for assessment
nd differentiation of the inflammatory processes in the liver
arenchyma from fibrosis [19–21]. This possibility to also assess
he inflammatory component in diffuse liver disease would be an 3 2.18 ± 0.29 2.50 ± 0.44 2.56 ± 0.55
 2 1.96 ± 0.02 2.49 ± 0.54 3.18 ± 0.62
 2 1.99 ± 0.26 2.54 ± 0.41 2.88 ± 0.54
 1 3.13 ± 0.64 3.86 ± 0.86 3.44 ± 0.80
a Fibrosis stage based on histopathological examination (see Table 1).
b Viscoelastic data presented as mean ± one standard deviation.
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Fig. 1. Viscoelastic maps and ROI positions for patient 7. (A) A conventional THRIVE image, acquired prior to the 3D MRE. The 3D MRE elasticity map is shown
in false colour in (B), with the ROI marked by a red outline (also shown overlaid on the THRIVE image in (A)). (C) The 2D MRE stiffness map in false colour,
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(nd in (D) the confidence mesh is shown overlaid on the 2D MRE stiffness map
alculations), as well as the ROI marked by a white outline. As can be seen in 
D and 3D MRE.
There are a few potential limitations when interpreting the
esults of the present study: (i) A relatively small sample size
as used. (ii) The biopsies were in some cases performed
p to 4 years prior to the MRE. Importantly, the biopsies
ere included in this work to show the spread of the fibrosis
tages in the patient cohort, and not to gauge the diagnos-
ic power of the MRE methods. (iii) The biopsies were not
patially correlated with the MRE ROIs. (iv) The patients
ere not required to fast prior to the examination, and the
ostprandial effect has been shown to affect the absolute stiff-
ess/elasticity values [22]. However, this postprandial effect
p
s
d
ig. 2. Correlation analysis of the viscoelastic properties. In both panels the data a
orrespond to one standard deviation, and the dashed lines correspond to the 95% co
nd stiffness, and (B) the correlation of ‘Gabs,Elastic’ and stiffness. In both comparisons
P < 0.001).ons excluded from the mesh correspond to regions with high confidence in the
nd (D) the ROIs are placed in the same anatomical region of the liver for both
robably had very little effect on the comparisons between the
wo systems since the patient examinations were obtained as
lose in time as was possible. (v) The driver frequencies were
ot identical (although very close) and this could also have
nfluenced the observed absolute values [23]. Despite these
imitations, we believe that this is an important addition to
he body of knowledge on using MRE in a clinical setting
ith different MRE methods. A central aspect of this small
atient group is that the spread in the fibrosis stages is pre-
umably representative for patients with suspected diffuse liver
isease in need of diagnostic workup. Also, the aetiology in
re presented as the mean value of the viscoelastic properties, the error bars
nfidence interval (CI) of the linear regression. (A) The correlation of elasticity
 R2 was equal to 0.96, and only the slope of the linear regression was significant
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his patient group is heterogeneous, which is a typical clinical
ituation.
In summary, this pilot study shows that different MRE meth-
ds can produce comparable measurements of the viscoelastic
roperties of the liver. The existence of such comparable mea-
urements is important, both from a clinical as well as a research
erspective, since it allows for equipment-independent monitor-
ng of disease progression.
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